2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

Cited by (159)

Items 101–159 of 159

1. Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape—focus on hypertriglyceridaemia
   Bashir, Bilal, Schofield, Jonathan, Downie, Paul, France, Michael, Ashcroft, Darren M., Wright, Alison K., Romeo, Stefano, Gouni-Berthold, Ioanna, Maan, Akhlaq, Durrington, Paul N. et al. · 2024 · Frontiers in Cardiovascular Medicine
2. Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: an analysis from BANTING and BERSON
   Lorenzatti, Alberto J., Monsalvo, Maria Laura, López, J. Antonio G., Wang, Huei, Rosenson, Robert S. · 2021 · Cardiovascular Diabetology
3. Examining the nocebo effect of statins through statin adverse events reported in the food and drug administration adverse event reporting system
   Moon, Jungyeon, Cohen Sedgh, Robert, Jackevicius, Cynthia A. · 2021 · Circulation: Cardiovascular Quality and Outcomes
4. Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol
   Colhoun, Helen M., Leiter, Lawrence A., Müller-Wieland, Dirk, Cariou, Bertrand, Ray, Kausik K., Tinahones, Francisco J., Domenger, Catherine, Letierce, Alexia, Israel, Marc, Samuel, Rita et al. · 2020 · Cardiovascular Diabetology
5. Dietary and Circulating Long-Chain Omega-3 Polyunsaturated Fatty Acids and Mortality Risk after Myocardial Infarction: A Long-Term Follow-up of the Alpha Omega Cohort
   Pertiwi, Kamalita, Küpers, Leanne K., de Goede, Janette, Zock, Peter L., Kromhout, Daan, Geleijnse, Johanna M. · 2021 · Journal of the American Heart Association
6. Lipid management for cardiovascular risk reduction in type 1 diabetes
   Tell, Shoshana, Nadeau, Kristen J., Eckel, Robert H. · 2020 · Current Opinion in Endocrinology, Diabetes & Obesity
7. PCSK9 inhibition: from effectiveness to cost-effectiveness
   Mercep, Iveta, Strikic, Dominik, Hrabac, Pero, Pecin, Ivan, Reiner, Željko · 2024 · Frontiers in Cardiovascular Medicine
8. Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trial
   Kristiansen, Oscar, Vethe, Nils Tore, Peersen, Kari, Wang Fagerland, Morten, Sverre, Elise, Prunés Jensen, Elena, Lindberg, Morten, Gjertsen, Erik, Gullestad, Lars, Perk, Joep et al. · 2021 · European Heart Journal - Cardiovascular Pharmacotherapy
9. Associations of hypertriglyceridemia onset age with cardiovascular disease and all-cause mortality in adults: a cohort study
   Zhou, Hui, Ding, Xiong, Yang, Qing, Chen, Shuohua, Li, Yun, Zhou, Xin, Wu, Shouling · 2022 · Journal of the American Heart Association
10. Effectiveness of fixed-dose combination therapy (polypill) versus exercise to improve the blood-lipid profile: a network meta-analysis
    Martínez-Vizcaíno, Vicente, Amaro-Gahete, Francisco J., Fernández-Rodríguez, Rubén, Garrido-Miguel, Miriam, Cavero-Redondo, Iván, Pozuelo-Carrascosa, Diana P. · 2022 · Sports Medicine
11. Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
    Michaeli, Daniel Tobias, Michaeli, Julia Caroline, Boch, Tobias, Michaeli, Thomas · 2023 · Cardiovascular Drugs and Therapy
12. Anti-obesity drug therapy in clinical practice: Evidence of a poor prescriptive attitude
    Squadrito, Francesco, Rottura, Michelangelo, Irrera, Natasha, Minutoli, Letteria, Bitto, Alessandra, Barbieri, Maria Antonietta, Cicala, Giuseppe, Mecchio, Anna, Pallio, Giovanni, Marino, Sebastiano et al. · 2020 · Biomedicine & Pharmacotherapy
13. Beyond the Cardiovascular Effects of Glucagon-like Peptide-1 Receptor Agonists: Body Slimming and Plaque Stabilization. Are New Statins Born?
    Lecis, Dalgisio, Prandi, Francesca Romana, Barone, Lucy, Belli, Martina, Sergi, Domenico, Longo, Susanna, Muscoli, Saverio, Romeo, Francesco, Federici, Massimo, Lerakis, Stamatios et al. · 2023 · Biomolecules
14. Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study
    van de Borne, Philippe, Peeters, André, Janssens, Luc, Leone, Attilio, Lemmens, Robin, Verhaegen, Ann, De Meulemeester, Marc, Balthazar, Yohan, Heijmans, Stéphane, Calozet, Yvan et al. · 2024 · Acta Cardiologica
15. PCSK9-directed therapies: an update
    Katzmann, Julius L., Laufs, Ulrich · 2024 · Current Opinion in Lipidology
16. Attainment of Low-Density Lipoprotein Cholesterol Goals in Statin Treated Patients: Real-World Evidence From Australia
    Talic, Stella, Marquina, Clara, Zomer, Ella, Ofori-Asenso, Richard, Petrova, Marjana, Vargas-Torres, Sandra, Abushanab, Dina, Wolfe, Rory, Lybrand, Sean, Thomson, David et al. · 2022 · Current Problems in Cardiology
17. Cost-Effectiveness of Icosapent Ethyl, Evolocumab, Alirocumab, Ezetimibe, or Fenofibrate in Combination with Statins Compared to Statin Monotherapy
    Michaeli, Daniel Tobias, Michaeli, Julia Caroline, Boch, Tobias, Michaeli, Thomas · 2022 · Clinical Drug Investigation
18. Very Low Calorie Ketogenic Diet: What Effects on Lipid Metabolism?
    Suarez, Rosario, Chapela, Sebastián, Llobera, Natalia Daniela, Montalván, Martha, Vásquez, Celina Andrade, Martinuzzi, Andres Luciano Nicolas, Katsanos, Christos S., Verde, Ludovica, Frias-Toral, Evelyn, Barrea, Luigi et al. · 2024 · Current Nutrition Reports
19. ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk
    Sehayek, Daniel, Cole, Justine, Björnson, Elias, Wilkins, John T., Mortensen, Martin B., Dufresne, Line, Pencina, Karol M., Pencina, Michael J., Thanassoulis, George, Sniderman, Allan D. · 2025 · Journal of Clinical Lipidology
20. Effects of a Mediterranean Diet, Dairy, and Meat Products on Different Phenotypes of Dyslipidemia: A Preliminary Retrospective Analysis
    Formisano, Elena, Pasta, Andrea, Cremonini, Anna Laura, Di Lorenzo, Ilaria, Sukkar, Samir Giuseppe, Pisciotta, Livia · 2021 · Nutrients
21. Low-density lipoprotein cholesterol goal attainment in Germany: Results from the DA VINCI study
    Gouni-Berthold, Ioanna, Schaper, Frank, Schatz, Ulrike, Tabbert-Zitzler, Anja, Fraass, Uwe, Sauer, Sarah, Ray, Kausik K. · 2022 · Atherosclerosis Plus
22. Oral PCSK9 Inhibitor Enlicitide Versus Oral Nonstatin Therapies
    Catapano, Alberico L., Mikhailova, Elina, Navar, Ann Marie, Banka, Puja, Corral, Pablo, Saxena, Manish, Steg, P. Gabriel, Verma, Subodh, Kordahi, Andrew Yacoub, Mendizabal, Geraldine et al. · 2026 · JACC
23. Translational <scp>Population‐Pharmacodynamic</scp> Modeling of a Novel <scp>Long‐Acting siRNA</scp> Therapy, Inclisiran, for the Treatment of Hypercholesterolemia
    Gosselin, Nathalie H., Schuck, Virna J. A., Barriere, Olivier, Kulmatycki, Kenneth, Margolskee, Alison, Smith, Patrick, He, YanLing · 2023 · Clinical Pharmacology &amp; Therapeutics
24. Remnant cholesterol and long-term incidence of death in coronary artery disease patients
    Drexel, Heinz, Mader, Arthur, Larcher, Barbara, Festa, Andreas, Vonbank, Alexander, Fraunberger, Peter, Leiherer, Andreas, Saely, Christoph H. · 2025 · Atherosclerosis
25. Inflammation and features of the vulnerable plaque: from mechanisms and imaging to outcomes
    Lüscher, Thomas F · 2020 · European Heart Journal
26. Fish oil supplements may increase the risk for atrial fibrillation: what does this mean?
    Samuel, Michelle, Nattel, Stanley · 2021 · Circulation
27. Dose-related meta-analysis for Omega-3 fatty acids supplementation on major adverse cardiovascular events
    Markozannes, Georgios, Ntzani, Evangelia E., Tsapas, Apostolos, Mantzoros, Christos S., Tsiara, Stavroula, Xanthos, Theodoros, Karpettas, Nikos, Patrikios, Ioannis, Rizos, Evangelos C. · 2022 · Clinical Nutrition
28. &lt;p&gt;Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date&lt;/p&gt;
    Jia, Xiaoming, Koh, Stephanie, Al Rifai, Mahmoud, Blumenthal, Roger S, Virani, Salim S · 2020 · Vascular Health and Risk Management
29. Adherence to dietary guidelines and risk of dementia: a prospective cohort study of 94 184 individuals
    Kjeldsen, E. W., Thomassen, J. Q., Rasmussen, K. L., Nordestgaard, B. G., Tybjærg-Hansen, A., Frikke-Schmidt, R. · 2022 · Epidemiology and Psychiatric Sciences
30. Effects of eligibility criteria on patient selection and treatment implications from 10 multidomain dementia prevention trials: a population-based study
    Licher, Silvan, Wolters, Frank J., Pavlović, Jelena, Kavousi, Maryam, Leening, Maarten J.G., Ikram, M. Kamran, Ikram, M. Arfan · 2023 · Neuroepidemiology
31. First Report of Inclisiran Utilization for Hypercholesterolemia Treatment in Real-world Clinical Settings in a Middle East Population
    Iqbal, Sajid, Sabbour, Hani Mohamed, Ashraf, Tanveer, Santos, Raul D., Buckley, Adam · 2024 · Clinical Therapeutics
32. Hypertriglyceridemia: molecular and genetic landscapes
    Scicchitano, Pietro, Amati, Francesca, Ciccone, Marco Matteo, D’Ascenzi, Flavio, Imbalzano, Egidio, Liga, Riccardo, Paolillo, Stefania, Pastore, Maria Concetta, Rinaldi, Andrea, Mattioli, Anna Vittoria et al. · 2024 · International Journal of Molecular Sciences
33. Therapy of Type 2 Diabetes
    Landgraf, Rüdiger, Aberle, Jens, Birkenfeld, Andreas L., Gallwitz, Baptist, Kellerer, Monika, Klein, Harald, Müller-Wieland, Dirk, Nauck, Michael A., Wiesner, Tobias, Siegel, Erhard · 2022 · Experimental and Clinical Endocrinology &amp; Diabetes
34. The Effect of Cooking and Cooling Chickpea Pasta on Resistant Starch Content, Glycemic Response, and Glycemic Index in Healthy Adults
    Bojarczuk, Adrianna, Kęszycka, Paulina, Marszałek, Krystian, Gajewska, Danuta · 2024 · Metabolites
35. Reduction of visit-to-visit LDL-C intraindividual variability in patients treated with PCSK9 inhibitors and inclisiran vs standard lipid-lowering therapy
    Cesaro, Arturo, Acerbo, Vincenzo, Scialla, Francesco, Zito, Andrea, Porcelli, Gennaro, Panico, Domenico, Argenziano, Giovanni, Iaria, Demetrio, Monaco, Maria Grazia, De Sio, Vincenzo et al. · 2026 · Journal of Clinical Lipidology
36. From clinical inertia to therapeutic optimization in patients with atherosclerotic cardiovascular disease: A Monte Carlo simulation within the ITACARE-P registry
    Faggiano, Andrea, Maloberti, Alessandro, Ambrosetti, Marco, Giallauria, Francesco, Mureddu, Gianfrancesco, Venturini, Elio, Ruzzolini, Matteo, Maranta, Francesco, Vatri, Marco, Zadre, Lana et al. · 2026 · Journal of Clinical Lipidology
37. Spectrum and Prevalence of Rare APOE Variants and Their Association with Familial Dysbetalipoproteinemia
    Blokhina, Anastasia V., Ershova, Alexandra I., Kiseleva, Anna V., Sotnikova, Evgeniia A., Zharikova, Anastasia A., Zaicenoka, Marija, Vyatkin, Yuri V., Ramensky, Vasily E., Kutsenko, Vladimir A., Garbuzova, Elizaveta V. et al. · 2024 · International Journal of Molecular Sciences
38. Sex-Related Differences in the Pharmacological Response in SARS-CoV-2 Infection, Dyslipidemia, and Diabetes Mellitus: A Narrative Review
    Lombrea, Adelina, Romanescu, Mirabela, Jianu, Narcisa, Andor, Minodora, Suciu, Maria, Man, Dana Emilia, Danciu, Corina, Dehelean, Cristina Adriana, Buda, Valentina · 2023 · Pharmaceuticals
39. The impact of inclisiran on lipid profiles in adults with hyperlipidemia: a meta-analysis and meta-regression of randomized controlled trials
    Khalil, Ibrahim, Rahman, Mohd Turzo, Hossain, Imran · 2025 · The American Journal of Cardiology
40. Remnant cholesterol, lipid ratios, and the severity of coronary artery lesions: a retrospective cohort study in patients with coronary heart disease
    Li, Yu, Zhai, Yumei, Hu, Songli, Liu, Jing, Zhang, Wenchen, Yue, Jianwei, Wang, Zichao · 2025 · Frontiers in Cardiovascular Medicine
41. Intolerance upon statin rechallenge: A systematic review and meta-analysis of randomized controlled trials
    Kraut, Roni, Wierenga, Faith, Molstad, Elisa, Korownyk, Christina, Perry, Danielle, Dennett, Liz, Garrison, Scott · 2023 · PLOS ONE
42. Interventions to improve adherence to lipid-lowering drugs: a systematic review and meta-analysis
    Yow, Deborah Keng Wai, Ang, Wei Jie, Yap, Hao Jeun, Ito, Sakura, Liu, Jintana, Ko, Junsuk, Tan, Doreen Su-Yin, Lorenzatti, Alberto, Ang, Chin-Siang · 2025 · eClinicalMedicine
43. The Efficacy and Safety of Plozasiran on Lipid Profile in Dyslipidemic Disorders: A Systematic Review and Meta-Analysis
    Sydhom, Pishoy, Al-Quraishi, Bakr, Gohar, Aya, El-Shawaf, Mohamad, Shehata, Nahla, Ataya, Miral, Sydhom, Mark, Awwad, Nouran, Motawade, Haidy, Naji, Nourhan et al. · 2026 · Cardiovascular Drugs and Therapy
44. A UK multicentre audit of the management of patients with primary hypercholesterolaemia or mixed dyslipidaemia with bempedoic acid against published lipid-lowering treatment targets
    Ramachandran, Sudarshan, Maarouf, Amro, Mitchell, Karen, Avades, Tony, Smith, Peter, Boulton, Lee, Kelly, Jennifer, Vekaria, Nitasha, Hughes, Elizabeth · 2024 · Drugs in Context
45. Organisational models supported by technology for the management of diabetic disease and its complications in a diabetic clinic setting study protocol for a randomised controlled trial targeting type 2 diabetes individuals with non-ideal glycaemic values (Telemechron study)
    Giovanazzi, Alexia, Gios, Lorenzo, Mastellaro, Marina, Gentilini, Maria Adalgisa, Valent, Francesca, Condini, Sara, Bincoletto, Giorgia, Bacchiega, Alessandro, Zorzi, Andrea, Malfatti, Giulia et al. · 2023 · Trials
46. Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes Trial
    Nicholls, Stephen J., Ray, Kausik K., Lincoff, A. Michael, Sarnes, Evelyn, Gillard, Kristin K., Bloedon, LeAnne, Migliaccio-Walle, Kristen, Elsea, David, Nissen, Steven E. · 2026 · American Journal of Cardiovascular Drugs
47. Quantifying patient preferences about features of nonstatin lipid-lowering therapies: a discrete choice experiment in the United States
    Reed, Shelby D., Sutphin, Jessie, Gonzalez, Juan Marcos, Wallace, Matthew J., Stephenson, Judith J., Electricwala, Batul, Bosworth, Hayden B., Pagidipati, Neha · 2025 · Circulation: Cardiovascular Quality and Outcomes
48. Small interfering RNA (siRNA) in dyslipidemia: a systematic review on safety and efficacy of siRNA
    Alla, Sai Santhosha Mrudula, Shah, Dhruv Jayeshkumar, Meyur, Shourya, Agarwal, Pahel, Alla, Deekshitha, Moraboina, Sai Lokesh, Ghadvaje, Gayatri Vijay, Bayeh, Ruth Getaneh, Malireddi, Aparna, Shajan, Tess et al. · 2025 · Journal of Experimental Pharmacology
49. Effects of fibrates on lipid profile: a meta-analysis of randomized controlled trials
    Olmastroni, Elena, Galimberti, Federica, Xie, Sining, Casula, Manuela, Catapano, Alberico L · 2025 · European Atherosclerosis Journal
50. Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies
    Alam, Usman, Mathai, Sheetal V., Filtz, Annalisa, Kuno, Toshiki, Badimon, Juan J., Sniderman, Allan D., Virani, Salim S., Toth, Peter P., Shapiro, Michael D., Lavie, Carl J. et al. · 2026 · Current Cardiology Reports
51. Genetic insights into causal effects of lipids and lipid-modifying targets on calcific aortic valve stenosis: a Mendelian randomized study
    Wu, Chengrong, Pu, Qian, Zou, Yalin, Jin, Juan, Lei, Yu, Hu, Yaxin, Chen, Zhuo, Yu, Lei · 2025 · Scientific Reports
52. Challenges in achieving LDL-C goals: Insights from the Italian SANTORINI study cohort
    Arca, Marcello, Calabrò, Paolo, Solini, Anna, Pirillo, Angela, Gambacurta, Rosanna, Ray, Kausik K., Catapano, Alberico L. · 2026 · Nutrition, Metabolism and Cardiovascular Diseases
53. Overall and sex-specific effect of berberine for dyslipidemia: systematic review and meta-analysis of placebo-controlled trials
    Blais, Joseph E, Huang, Xin, Zhao, Jie V · 2022 · medRxiv
54. Saturated Fat Restriction for Cardiovascular Disease Prevention: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    2025 · JMA Journal
55. Efficacy and Safety of Apolipoprotein C‐ <scp>III</scp> Inhibitors in Hypertriglyceridemia: A Network Meta‐Analysis of Randomised Controlled Trials
    Elbahloul, Mohammed A., Gamal, Aliaa, Maihoub, Odai, Elbaz Hassan, Moustafa M., Attia, Manar Khaled, Salah, Ahmed M., Elboraay, Toka, Awad, Ayman K., Akoum, Atef, Elazab, Ahmed et al. · 2026 · Diabetes, Obesity and Metabolism
56. Dietary Interventions for Hypertriglyceridemia
    Kirkpatrick, Carol F., Petersen, Kristina S., Kris-Etherton, Penny M., Maki, Kevin C. · 2026 · Current Atherosclerosis Reports
57. Safety outcomes of statin vs non-statin lipid-lowering interventions in patients with prior statin-associated muscle symptoms: A systematic review and meta-analysis
    Aebi, Philipp Stefan, Villoz, Fanny, Bührer, Jonas, Lyko, Christina, Abolhassani, Nazanin, Del Giovane, Cinzia, Gencer, Baris, Rodondi, Nicolas, Blum, Manuel R. · 2025 · PLOS One
58. Targeting triglycerides for cardiovascular risk reduction
    Maiorca, Carlo, Tramontano, Daniele, Di Costanzo, Alessia, D’Erasmo, Laura · 2026 · Internal and Emergency Medicine
59. Effectiveness and Safety of Target-Specific RNA-Based Lipid-Lowering Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Widjaja, Jordan Steven, Adji, Arga Setyo, Baraja, Aufa, Dharmasaputra, Alan, Rosyadi, Ragil Nur, Komalasari, Intan, Mustofa, Ali, Multazam, Chaq El Chaq Zamzam, Alkaff, Firas Farisi, Saputra, Pandit Bagus Tri · 2026 · European Journal of Pharmacology